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SUMMARY 21 
All living cells are subject to agents that promote DNA damage. A particularly lethal 22 
lesion are interstrand crosslinks (ICL), a property exploited by several anti-cancer 23 
chemotherapies. In yeast and humans an enzyme that plays a key role in repairing such 24 
damage are the PSO2/SNM1 nucleases. Here, we report that Trypanosoma brucei, the 25 
causative agent of African trypanosomiasis, possesses a bona fide member of this family 26 
(called TbSNM1) with expression of the parasite enzyme able to suppress the sensitivity 27 
yeast pso2∆ mutants display toward mechlorethamine, an ICL-inducing compound. By 28 
disrupting the Tbsnm1 gene, we demonstrate that TbSNM1 activity is non-essential to the 29 
medically relevant T. brucei life cycle stage. However, trypanosomes lacking this enzyme are 30 
more susceptible to bi- and tri-functional DNA alkylating agents with this phenotype readily 31 
complemented by ectopic expression of Tbsnm1. Genetically modified variants of the null 32 
mutant line were subsequently used to establish the anti-parasitic mechanism of action of 33 
nitrobenzylphosphoramide mustard and aziridinyl nitrobenzamide prodrugs, compounds 34 
previously shown to possess potent trypanocidal properties while exhibiting limited toxicity 35 
to mammalian cells. This established that these agents, following activation by a parasite 36 
specific type I nitroreductase, produce metabolites that promote formation of ICLs leading to 37 
inhibition of trypanosomal growth.  38 
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INTRODUCTION 39 
The socioeconomic development of sub-Saharan Africa has been hindered by a group of 40 
medical and veterinary infections collectively known as African trypanosomiasis. The 41 
causative agents of many of these diseases are protozoan parasites belonging to the species 42 
Trypanosoma brucei, organisms that live and multiply extracellularly in the bloodstream and 43 
tissue fluids of their mammalian hosts. Transmission occurs via the blood-feeding habits of 44 
the insect vector, the tsetse fly. Over the last 15 years implementation of improved health 45 
surveillance programmes combined with new treatment regimens has led to a dramatic fall in 46 
the estimated number of new cases of the human form of the disease, known as human 47 
African trypanosomiasis (HAT) from around 450,000 in 1997 to about 20,000 in 2012 48 
(Barrett, 2006, WHO 2014). This situation has resulted in WHO aiming to eliminate HAT as 49 
a public health problem by 2020. In contrast, animal African trypanosomiasis, particularly in 50 
domesticated livestock, remains a major problem with these infections killing around 3 51 
million head of cattle each year and causing an annual loss of income estimated to be about 52 
US$4.75 billion (UNFAO, 2004). 53 
With no immediate prospect of a vaccine or chemoprophylaxis and with vector control 54 
being problematic, drug treatment represents the only option available to combat HAT. 55 
However, the current chemotherapies used are few in number and their use is controversial, 56 
as they can be costly, often require medical supervision for administration, some have limited 57 
efficacy and may cause adverse side effects, with drug resistance becoming more widespread 58 
(Wilkinson and Kelly 2009, Alsford et al., 2013). One way to facilitate the development of 59 
new drugs targeting HAT is to better understand the mechanism of action of existing 60 
treatments with the properties that underlie parasite selectivity incorporated into the 61 
development of new trypanocidal agents. For example, melamine rings have been 62 
incorporated into several compounds to exploit the substrate specificity displayed by the P2 63 
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adenosine transporter, a permease implicated in the uptake of pentamidine and melarsoprol 64 
(Stewart et al., 2004, Baliani et al., 2005, Chollet et al., 2009, Klee et al., 2010, Capes et al., 65 
2012, Giordani et al., 2014). Similarly a parasite nitroreductase (NTR), an enzyme 66 
responsible for the activation of nifurtimox (Wilkinson et al., 2008, Hall et al., 2011), has 67 
been used to screen nitroaromatic libraries for anti-T. brucei properties (Bot et al., 2010, Hall 68 
et al., 2010, Hu et al., 2011, Papadopoulou et al., 2011, Hall et al., 2012, Papadopoulou et 69 
al., 2012, Bot et al., 2013, Papadopoulou et al., 2013). In the latter case, several NTR-70 
activated chemicals containing nitrogen mustard or aziridine functional groups that promote 71 
DNA damage via formation of cross linkages, have been identified as having significant anti-72 
parasitic activities and low mammalian cell toxicity (Bot et al., 2010, Hall et al., 2010, Hu et 73 
al., 2011).  74 
Genomes are constantly challenged by endogenous and exogenous agents that promote 75 
DNA damage, with interstrand crosslinks (ICL) representing a particularly dangerous lesion 76 
(O'Connor and Kohn, 1990). Formed when the two complementary strands within the DNA 77 
double helix become covalently linked, ICL’s block essential cellular process that require 78 
DNA strand separation including DNA replication and transcription, leading to chromosomal 79 
breakage, rearrangements, or cell death (Dronkert and Kanaar, 2001, McHugh et al., 2001, 80 
Deans and West, 2011, Sengerova et al., 2011). Estimates indicate that a single ICL can kill a 81 
unicellular microbe with as few as 20 being fatal to a mammalian cell (Magana-Schwencke, 82 
Henriques et al. 1982, Lawley and Phillips 1996). In order to preserve the integrity and 83 
functionality of DNA eukaryotic cells have evolved a series of complementary and 84 
overlapping pathways to repair ICLs, although the precise mechanisms involved in these 85 
systems are not fully understood (Deans and West, 2011). In Saccharomyces cerevisiae many 86 
of the major DNA repair pathways (nucleotide excision repair (NER), mismatch repair, post-87 
replication repair/translesion synthesis and homologous recombination) have been implicated 88 
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in fixing ICL damage although only a few proteins specifically involved in ICL lesion repair 89 
have been identified (Barber et al., 2005, Lehoczky et al., 2007, Daee et al., 2012, Ward et 90 
al., 2012). Of these, Pso2p (also known as Snm1) is of great interest as cells lacking this 91 
activity are specifically and highly susceptible to ICL-forming agents including psoralen, 92 
cisplatin and mechlorethamine but not to any other forms of DNA damage (Henriques and 93 
Moustacchi, 1980, Ruhland et al., 1981a, Ruhland et al., 1981b). The precise role played by 94 
Pso2p in this repair system remains unknown although biochemical studies have shown that 95 
it displays a 5' exonuclease activity (Li et al., 2005). This coupled with the observation that 96 
pso2∆ cells exposed to ICL-inducing compounds tend to accumulate DNA double stranded 97 
breaks indicates that Pso2p does not function in the initial incision event, which in yeast is 98 
primarily controlled by NER, but may be involved in the processing of DNA ends created 99 
during the generation of ICL-associated DNA double stranded breaks (Li and Moses, 2003, 100 
Barber et al., 2005, Dudas et al., 2007).  Intriguingly, Pso2p also displays a structure-specific 101 
DNA hairpin opening endonuclease activity providing evidence that it may have other 102 
functions outside ICL repair (Tiefenbach and Junop, 2012).  103 
Here, we report that T. brucei expresses a Pso2/Snm1 homologue that can readily 104 
complement for the susceptibility phenotype exhibited by pso2∆ yeast cells towards an ICL 105 
forming agent. Deletion of the gene, designated Tbsnm1, from the parasite genome revealed 106 
that although the encoded enzyme is not essential for viability and growth of bloodstream 107 
form (BSF) trypanosomes, cells lacking this activity were more susceptible to bifunctional 108 
nitrogen mustard- and aziridine-based ICL-inducing agents. Using recombinant T. brucei 109 
expressing altered levels of Tbsnm1 we establish that the trypanocidal mechanism of several 110 
potent nitroaromatic-based agents that contain ICL-promoting grouping are dependent on an 111 
initial activation catalysed by a parasite specific type I NTR that generates metabolites which 112 
then promote DNA damage.  113 
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RESULTS 114 
Identifying trypanocidal chemical tools for studying DNA repair. 115 
Previous screening studies have identified nitroaromatic-based azirindyl/nitrogen mustard 116 
compounds to be effective trypanocidal agents (Bot et al., 2010, Hall et al., 2010, Hu et al., 117 
2011). The antimicrobial activity of these involves a parasite specific activation step 118 
catalysed by a type I NTR that leads to metabolites postulated to promote DNA damage. To 119 
determine if the above compounds do function via this pathway a range of anti-cancer 120 
compounds known to mediate their cytotoxicity by promoting DNA cross linkages were 121 
screened for trypanocidal activity against BSF T. brucei. The structures tested included non-122 
nitroaromatic-based aziridines and nitrogen mustards, nitrosoureas, platinum complexes, an 123 
alkyl sulfonate and non-classical DNA crosslinking agents. 124 
Out of the non-nitroaromatic anti-cancer compounds assessed, 17 had no effect on parasite 125 
growth at concentrations of up to 30 µM, including busulfan, the only alkyl sulfonate 126 
analysed here, and all 5 non-classical DNA crosslinking agents (Table 1). These were not 127 
analysed further. For the remaining compounds, the concentration that inhibits parasite 128 
growth by 50 % (IC50
’
s) was determined (Table 1). For all the remaining classes of DNA 129 
crosslinking agents, two or more compounds displayed trypanocidal activities with IC50 130 
values ranging from 13 nM for mitomycin C, the most potent agent identified here, to 131 
approximately 35 µM for mechlorethamine and ThioTEPA. 132 
 133 
Identification of the DNA repair enzyme TbSNM1. 134 
In other eukaryotes, the SNM1/PSO2 family of nucleases play an important role in 135 
repairing damage caused by DNA crosslinking agents (Cattell et al., 2010). Analysis of the T. 136 
b. brucei genome database (Aslett et al., 2010) identified a single hypothetical gene 137 
(designated as Tbsnm1) of 2163 bp located on chromosome 4 with potential to encode for a 138 
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79.5 kDa enzyme (TbSNM1; Gene ID: Tb927.4.1480) related to this family of enzymes. Full 139 
length TbSNM1 is 42 % identical to the T. cruzi homologue (GenBank accession no. 140 
XP_816034) and has 27-32% identity to the leishmanial enzymes LmSNM1 141 
(XP_001686430) and LdSNM1 (XP_003864463). When compared to yeast, plant and 142 
mammalian counterparts sequence identity ranged from 15 to 24 %. Based on sequence, 143 
TbSNM1 can be divided into two regions (Fig. 1). The amino terminal section (residues 36-144 
182) constitutes a non-canonical metallo-ß-lactamase (MBL; pfam12706) domain containing 145 
4 motifs (motifs 1-4), including a characteristic HxHxDH signature (motif 2), that in other 146 
SNM1/PSO2 proteins cooperate to mediate zinc co-factor binding. The second section 147 
represents a β-CASP (named after its representative member CPSF, Artemis, SNM1 and 148 
PSO2; pfam10996) region (residues 213-519) that contains within it a stretch of 31 amino 149 
acid comprising a DRMBL (DNA repair metallo-ß-lactamase; pfam07522) domain (residues 150 
488-519). The β-CASP region contains a fifth zinc binding motif (motif 5) but as with other 151 
SNM1/PSO2 sequences the precise location of this has yet to be defined: in silico analysis of 152 
TbSNM1 indicates that D220 or H497 (motifs 5’ and 5’’, respectively) may fulfil this role 153 
with H497 being the most likely of the two candidate residues (Callebaut et al., 2002). The β-154 
CASP domain of TbSNM1 also contains a diagnostic valine residue (position 519) that 155 
indicates that the parasite enzyme is involved in DNA processing: DNA processing MBLs 156 
contain a valine residue at the equivalent site while RNA processing MBLs contain a 157 
histidine (Callebaut et al., 2002). 158 
To investigate whether the T. brucei enzyme is a SNM1/PSO2 homologue, Tbsnm1 minus 159 
its ATG initiation codon was amplified and cloned into a version of the yeast expression 160 
vector pYCYlac111 that contains a DNA sequence encoding for the FLAG-tag epitope. The 161 
resultant plasmid was transformed into the S. cerevisiae wild type and pso2∆ strains and 162 
expression of recombinant TbSNM1 confirmed by western blot analysis (Fig. 2A). The 163 
Page 7 of 41 Molecular Microbiology
For Peer Review
8 
 
susceptibility of the fungal lines to mechlorethamine, a DNA crosslinking agent, was then 164 
determined and from the resultant dose-response curves the IC50 value for each strain 165 
calculated (Fig. 2B and C). Yeast lacking pso2 were clearly more susceptible to the nitrogen 166 
mustard than wild type with the null mutant displaying an IC50 value approximately 40% that 167 
of the control strain. When Tbsnm1 was expressed in wild type yeast a slight (1.4-fold) 168 
resistance was noted.  This phenotype was also observed in the pso2∆ strain expressing 169 
Tbsnm1 correlating with an increase in the IC50 value from 1.3 µM in cells lacking Pso2p to 170 
5.7 µM in pso2∆ yeast expressing FLAG-TbSNM1. These data clearly shows that TbSNM1 171 
can complement for the pso2∆ mutation and that the trypanosomal enzyme is a bona fide 172 
SNM1/PSO2 homologue. 173 
 174 
TbSNM1 is targeted to the T. brucei nucleus. 175 
When analysed using the PSORTII and WoLFPSORT algorithms, TbSNM1 was predicted 176 
to be targeted to the nucleus via a 'four pattern' RRH (residues 428-431) nuclear localisation 177 
signal. To confirm this, the full length Tbsnm1 gene minus its ATG initiation codon was 178 
amplified and ligated in-frame and downstream of the gene encoding for the enhanced green 179 
fluorescence protein (GFP) in a trypanosomal vector that facilitated tetracycline inducible 180 
gene expression (Alsford et al. 2005). The resultant construct was used to transform BSF T. 181 
brucei and parasite clones were selected. 182 
To induce expression of the tagged protein, cells were incubated in the presence of 183 
tetracycline for 48 hours. Recombinant parasites were examined by Western blotting using a 184 
monoclonal antibody against GFP (Fig. 3A), with extracts derived from these cells containing 185 
a band of the expected size (~105 kDa), or were fixed and examined by confocal microscopy 186 
(Fig. 3B). For parasites expressing GFP-TbSNM1, GFP fluorescence was restricted to a large 187 
single spot, a pattern reported for trypanosomal proteins localized to nucleus (Fig. 3B). To 188 
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confirm this, cells were co-stained with the DNA dye, DAPI. When the images were 189 
compared, the pattern of localization indicated that GFP-TbSNM1 was located in the larger 190 
of two compartments (the nucleus) where DAPI is found with the smaller, faint spot 191 
corresponding to the kinetoplast, the genome found in the parasites’ single mitochondrion. 192 
 193 
Functional Analysis of TbSNM1 in T. brucei. 194 
To assess whether TbSNM1 was essential to BSF T. brucei an RNAi–based approach was 195 
initially employed. A DNA fragment corresponding to an internal region of Tbsnm1 was 196 
cloned into p2T7Ti (Wilkinson et al., 2003) and the construct transformed into BSF T. brucei. 197 
In the absence of tetracycline, recombinant clones were found to grow at approximately the 198 
same rate as the parental cells. Addition of tetracycline to parasites harbouring the RNAi 199 
construct did not affect the growth rate suggesting that TbSNM1 is not essential to BSF T. 200 
brucei. To confirm this, DNA fragments corresponding to the 5’ flank of Tbsnm1 and the 3’ 201 
region of the Tbsnm1 gene were cloned either side of a cassette containing blasticidin or 202 
puromycin resistance markers. The integration constructs were transformed into BSF T. 203 
brucei with heterozygote (Tbsnm1
+/-
) and then null mutant (Tbsnm1
-/-
) lines selected. 204 
Southern hybridisation was used to confirm each integration event demonstrating that both 205 
copies of the Tbsnm1 gene could readily be deleted from the parasite genome (Fig. 4A and B) 206 
while qPCR data analysed using the comparative CT method showed that a full length 207 
Tbsnm1 mRNA was not expressed (data not shown) (Schmittgen and Livak, 2008). 208 
Reduction or lack of TbSNM1 had no effect on trypanosome growth (data not shown). 209 
Therefore, TbSNM1 is non-essential to BSF T. brucei under normal culture conditions 210 
confirming the RNAi observations. 211 
To evaluate whether deletion of both copies of Tbsnm1 from the T. brucei genome altered 212 
sensitivity to chemicals that promote DNA cross linkage, null mutant cells were grown in the 213 
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presence of these agents and the IC50 values for each compound determined (Table 1). Cells 214 
lacking TbSNM1 were more susceptible to a range of nitrogen mustard and aziridinyl 215 
compounds, including several of the trypanocidal nitroaromatic structures previously 216 
identified (Bot et al., 2010, Hall et al., 2010, Hu et al., 2011). Intriguingly, Tbsnm1-/- cells 217 
exhibited a larger difference in their sensitivities to the nitrogen mustards screened than that 218 
observed when using the aziridinyl compounds. When these growth assays were extended to 219 
look at other DNA damaging agents including mitomycin C, semustine, cisplatin, MMS, 220 
H2O2, hydroxyurea and UV light, and to the clinically used trypanocidal drugs nifurtimox, 221 
benznidazole or difluoromethylornithine (DFMO), no difference in IC50 was observed. 222 
 In order to demonstrate conclusively that the altered susceptibility phenotypes were 223 
specifically due to lack of TbSNM1, a complementation strategy was used. In these 224 
experiments Tbsnm1-/- cells were transformed with a vector that facilitates constitutive 225 
expression of an ectopic copy of Tbsnm1 integrated into one of the parasite’s tubulin arrays: 226 
wild type cells also expressing this vector were also generated. The IC50 of these parasites 227 
towards selected nitrogen mustard and aziridinyl compounds was determined and compared 228 
with values obtained using wild type and Tbsnm1 null mutant lines (Fig. 5A). When the 229 
susceptibility of the complemented line to the nitrobenzyl-containing nitrogen mustard 230 
(LH34) and aziridinyl (NH1) compounds was tested, the resultant dose response curves (and 231 
associated IC50 values) were distinct from the Tbsnm1
-/- cells, which displayed increased 232 
sensitivity to both agents, and equivalent to the plots observed using Tbsnm1 expressing 233 
parasites (wild type and wild type cells engineered to express elevated levels of TbSNM1) 234 
(Fig. 5A). When the screens were extended to investigate the complemented line’s 235 
susceptibility to non-nitroaromatic nitrogen mustard (mechlorethamine) and aziridinyl 236 
(triethylenemelamine) compounds, a resistance phenotype was noted, with the dose response 237 
curves (and associated IC50 values) in the complemented line mirroring that obtained for wild 238 
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type parasites expressing elevated levels of TbSNM1 (Fig. 5A): trypanosomes (wild type and 239 
Tbsnm1 null mutants) expressing an ectopic copy of Tbsnm1 were up to 2.1-fold more 240 
resistant to mechlorethamine and triethylenemelamine than wild type.  241 
The above complementation studies indicate that parasites (wild type or Tbsnm1-/-) 242 
ectopically expressing Tbsnm1 are resistant to non-nitroaromatic DNA crosslinking agents 243 
but not to the nitroaromatic-containing compounds. One reason for this could reflect that the 244 
latter structures function as prodrugs and must undergo an NTR catalysed activation step 245 
before mediating their trypanocidal DNA damaging activities. 246 
 247 
Linking prodrug activation with DNA damage. 248 
To identify any link between the DNA damaging and the NTR-activating pathways, both 249 
copies of the Tbsnm1 gene were deleted from T. brucei cells expressing an ectopic copy of 250 
Tbntr and the susceptibilities of these recombinant cells towards selected nitrogen mustard 251 
and aziridinyl compounds determined (Fig. 5B). When treated with mechlorethamine or 252 
triethylenemelamine, both Tbsnm1 expressing cell lines (wild type and trypanosomes 253 
expressing elevated levels of Tbntr) displayed similar dose response curves and therefore had 254 
similar IC50’s to either agent (Fig. 5B). When these studies were expanded to investigate the 255 
susceptiblity of parasites lacking TbSNM1, the Tbsnm1-/- null mutant line and Tbsnm1-/- cells 256 
expressing the ectopic copy of Tbntr displayed equivalent IC50 values, with both being more 257 
sensitive to mechlorethamine and triethylenemelamine than wild type (Fig. 5B). Importantly, 258 
no difference in IC50 was observed using either of the lines lacking Tbsnm1 indicating that 259 
Tbntr plays no role in metabolising either mechlorethamine or triethylenemelamine. 260 
When the nitrobenzyl-containing DNA crosslinking agents LH34 and NH1 were tested 261 
against the parasite lines expressing altered levels of Tbsnm1 and/or Tbntr a different 262 
outcome was observed (Fig. 5B). For Tbsnm1-/- parasites or wild type cells expressing an 263 
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ectopic copy of Tbntr, treatment with either damaging agents resulted in increased 264 
susceptibility when compared against controls, with Tbntr over expressing trypanosomes 265 
being more sensitive to LH34 and NH1 than the null mutant lines: Tbsnm1-/- cells and T. 266 
brucei over expressing Tbntr were 18.0- and 24.0-fold more susceptible to LH34, 267 
respectively, with a 2.7- and 31.1-fold increase in sensitivity noted towards NH1. For 268 
Tbsnm1
-/-
 null parasites expressing an ectopic copy of Tbntr this increase in potency was 269 
magnified further with these cells showing a 80.0- and 38.7-fold increase in susceptibility 270 
towards LH34 and NH1, respectively, when as compared against wild type. 271 
 272 
DISCUSSION 273 
Currently, very little is known about the mechanisms T. brucei employs to repair ICL 274 
damage even though this parasite is exposed to such deleterious insults throughout its cell and 275 
life cycles. In other unicellular eukaryotes such as budding and fission yeast, the processing 276 
of ICLs occurs through the concerted activities of several major DNA repair pathways with 277 
one enzyme, Pso2p, playing a central and specific role in fixing such lesions. Although non-278 
essential for yeast viability, the importance of Pso2p is only apparent in its absence on 279 
exposure to ICL-inducing, bifunctional alkylating agents but not to monofunctional 280 
alkylating agents, ionizing radiation or ultraviolet light (Henriques and Moustacchi, 1980, 281 
Ruhland et al., 1981a, Ruhland et al., 1981b). Here, we report the characterisation of 282 
TbSNM1, a trypanosomal Pso2p homologue, and demonstrate that this enzyme plays a key 283 
role in processing ICL lesions when generated by bifunctional nitrogen mustard and 284 
aziridinyl compounds including several nitroaromatic-based agents previously shown to have 285 
potent anti-trypanosomal properties with low toxicity to mammalian cells (Bot et al. 2010, 286 
Hall et al., 2010, Hu et al., 2011). 287 
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In terms of its sequence, TbSNM1 displays the main characteristics found in other 288 
PSO2/SNM1 proteins, possessing adjacent MBL and β-CASP domains that together form the 289 
enzyme’s zinc-binding central catalytic core (Cattell et al., 2010). To confirm the in silico 290 
identification a complementation approach was undertaken. This involved ectopically 291 
expressing the trypanosomal enzyme in a yeast pso2∆ line and then evaluating the 292 
susceptibility of the resultant cells to mechlorethamine, a bifunctional alkylating agent 293 
routinely used as an ICL-inducing agent. In this genetic background the parasite protein was 294 
able to revert the susceptibility phenotype displayed by the pso2∆ line resulting in an 295 
additional slight (approximately 2-fold) resistance towards this nitrogen mustard. This 296 
confirmed that the trypanosomal enzyme is a genuine Pso2p homologue and that it plays a 297 
role in the processing of ICL lesions. Further, as TbSNM1 can complement for the pso2 298 
mutation then the parasite enzyme may interact with the same partner proteins as its yeast 299 
counterpart. For example, Pso2p contains an ubiquitin binding zinc finger (UBZ) C2HC 300 
motif upstream of its catalytic core (Yang et al., 2010). By analogy with hSNM1A, the only 301 
human PSO2/SNM1 homologue able to complement the yeast pso2 mutation (Hazrati et al., 302 
2008), this signature sequence is able to facilitate binding to monoubiquinated PCNA leading 303 
to recruitment of this repair enzyme to ICL-stalled replication forks (Yang et al., 2010). 304 
Interestingly, in silico searches failed to identify any known UBZ C2HC domain or any other 305 
type of ubiquitin interaction motifs (UIM) in the parasite protein sequence. Therefore, if 306 
formation of PSO2/SNM1-containing DNA repair complexes at the site of ICL damage does 307 
involve PCNA ubiquitylation then the molecular mechanisms underlying TbSNM1 308 
recruitment to such lesions occurs through an as yet uncharacterised UIM or via interactions 309 
involving a conserved adapter protein. Recently, it has been shown that the β-CASP domain 310 
of Pso2p can be phosphorylated leading to the suggestion that this event may play a role in 311 
modulating the enzyme’s exo- or endo-nucleolytic activity (Munari et al., 2014). Whether 312 
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TbSNM1 undergoes a similar posttranslational modification and how this effects its nuclease 313 
activity has yet to be established. 314 
The endogenous function of TbSNM1 is non-essential to replicating T. brucei: both copies 315 
of Tbsnm1 could be deleted from the genome of BSF trypomastigote parasites. However, the 316 
importance of this enzyme to the trypanosome only became evident following exposure to 317 
ICL-inducing compounds: null mutant cells were more susceptible to bi- and tri-functional 318 
alkylating agents as compared to controls while these recombinant cells display an equivalent 319 
sensitivity to wild type when exposed to MMS, UV irradiation and H2O2, treatments 320 
normally repaired by homologous recombination, nucleotide excision repair or base excise 321 
repair pathways. This trait was solely due to loss of TbSNM1 activity as expression of an 322 
ectopic copy of Tbsnm1 in the null mutant genetic background restored the recombinant 323 
parasites IC50 near to wild type levels. Intriguingly, the range of compounds that elicits the 324 
change in susceptibility in the Tbsnm1-/- trypanosomes although similar to that noted for the 325 
yeast pso2∆ line does have some notable differences (Henriques and Moustacchi, 1980, 326 
Ruhland et al., 1981a, Ruhland et al., 1981b). For example, yeast pso2 mutants are reported 327 
to be more susceptible to cisplatin and mitomycin C while T. brucei lacking TbSNM1 display 328 
sensitivities similar to that exhibited by wild type parasites. This may be because that 329 
although both compounds can function as ICL-inducing agents they can also mediate their 330 
cytotoxic activities via other mechanisms including promoting formation of intrastrand 331 
crosslinks, activating signal transduction pathways, stimulating redox cycling, acting as 332 
enzyme inhibitors or alkylating other biological molecules (Sharma and Tomasz, 1994, 333 
Pagano et al., 2003, Siddik, 2003, Rabik and Dolan, 2007, Paz et al., 2012). One (or a 334 
combination) of these alternative modes of action (or possibly another unidentified 335 
mechanism) may account for cisplatin’s and mitomycin C’s trypanocidal properties therefore 336 
negating the requirement for a TbSNM1-dependent ICL repair pathway. 337 
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Previous trypanocidal screening programmes have identified nitrobenzylphosphoramide 338 
mustards (NBPMs) and aziridinyl nitrobenzamides (ANBs) as having potent anti-parasitic 339 
activity (Bot et al. 2010, Hall et al., 2010, Hu et al., 2011). These agents function as prodrugs 340 
and must be activated before they can mediate their cytotoxic effects, a reaction catalysed a 341 
NADH dependent type I NTR. This reduction causes the conversion of a conserved electron 342 
withdrawing nitro-group present on the compound’s benzyl ring to an electron donating 343 
hydroxylamine derivative (Bot et al. 2010, Hall et al., 2010, Hu et al., 2011). This action 344 
effectively acts as an electronic switch that is believed to turn on the alkylating ability of the 345 
nitrogen mustard or aziridinyl moiety causing ICL-mediated DNA damage. Using Tbsnm1 346 
null mutant parasites engineered to express elevated levels of TbNTR we have now 347 
demonstrated a link between prodrug activation and ICL formation. Here we observed that 348 
wild type parasites exhibited the highest IC50 values towards LH34 (a 349 
nitrobenzylphosphoramide mustard) and NH1 (an aziridinyl nitrobenzamide) while 350 
trypanosomes lacking TbSNM1 and cells over expressing TbNTR had intermediate 351 
sensitivities. Interestingly, Tbsnm1 null mutants that also express elevated levels of TbNTR 352 
were the most prone to both compounds. This implies that following uptake, LH34 and NH1 353 
are transported into mitochondrion where they undergo TbNTR mediated reduction to form 354 
the bioactive products. These observations suggest that in parasites where the NTR activity is 355 
over expressed this conversion occurs at a faster rate than in wild type cells resulting in 356 
increased sensitivity to the compound. A portion of the resulting metabolites are then able to 357 
access the nucleus where they induce ICL formation. In the absence of TbSNM1, mutant 358 
cells are less able to repair this type of DNA damage, resulting in an increased susceptibility 359 
to the ICL-inducing agent. In parasites where both TbSNM1 and TbNTR levels have been 360 
altered, this susceptibility phenotype is exacerbated. Intriguingly, the difference in 361 
sensitivities between Tbsnm1-/- cells expressing elevated TbNTR levels from those over 362 
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expressing TbNTR alone was greater for LH34 than for NH1. This may be attributable to 363 
properties of the substrate/TbNTR-generated metabolites, possibly reflecting differences in 364 
cell and/or organelle uptake (TbNTR is a mitochondrial protein (Wilkinson et al 2008) or 365 
how the substrates interact with, or how the metabolites are released from, TbNTR (in vitro 366 
nitrobenzyl phosphoramide nitrogen mustard-based compounds interact with TbNTR more 367 
readily than the aziridinyl nitrobenzamide (Hall et al., 2013). Additionally, as this study only 368 
considers ICL formation and repair in the nuclear genome, it is plausible that LH34 and NH1 369 
reduction products may also affect the mitochondrial genome with the NH1 metabolites 370 
preferentially affecting this DNA containing region and not the nucleus. 371 
We have now demonstrated that T. brucei expresses a bona fide homologue of the 372 
PSO2/SNM1 nuclease family. The trypanosomal enzyme displays characteristics of its yeast 373 
counterpart and is able to repair the DNA damage caused by bi- and tri-functional alkylating 374 
agents. By exploiting parasites lacking this enzyme we were able to demonstrate that 375 
following TbNTR-mediated activation nitrobenzylphosphoramide mustard and aziridinyl 376 
nitrobenzamide agents, compounds previously shown to have potent trypanocidal properties 377 
with little/no cytotoxicity in mammalian cells, generate metabolites that promote ICL 378 
formation. Although not essential to survival of the medically relevant form of T. brucei, in 379 
the future TbSNM1 could be targeted through the use of inhibitors to improve the potency of 380 
other drugs that do cause parasite death through formation of the extremely lethal ICL. 381 
 382 
EXPERIMENTAL PROCEDURES 383 
Cell culturing. Bloodstream form Trypanosoma brucei brucei (MITat 427 strain; clone 221a 384 
and a derivative (2T1) engineered to express elevated levels of TbNTR-myc) were 385 
maintained in HMI-9 (Invitrogen) medium supplemented with 3g l
-1
 sodium bicarbonate, 386 
0.014 % (v/v) β-mercaptoethanol and 10 % (v/v) foetal calf serum (Hirumi and Hirumi, 1989, 387 
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Wilkinson et al., 2008) at 37 °C under a 5 % (v/v) CO2 atmosphere. The 2T1 cells were 388 
grown in the presence of 1 µg ml-1 phleomycin and 2 µg ml-1 puromycin. Transformed T. 389 
brucei cells were grown in the presence of 2.5 µg ml-1 hygromycin, 10 µg ml-1 blasticidin 390 
and/or 2 µg ml-1 puromycin. 391 
S. cerevisiae strains BY4742 (MATα his3-∆1 leu2-∆0 lys2-∆0 ura3-∆0) and a pso2∆ 392 
derivative obtained from the Open Biosystems (Thermo Scientific) knock-out collection were 393 
maintained in yeast extract-peptone broth containing 2 % (w/v) glucose. Transformed cells 394 
were grown in Synthetic Complete Dropout medium lacking leucine (Sigma). 395 
 396 
Chemicals. The DNA damaging agents were obtained from Drug Synthesis and Chemistry 397 
Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, 398 
National Cancer Institute except CB1954, H2O2, methyl methanesulphonate (MMS) and 399 
hydroxyurea (all Sigma-Aldrich), NH1 (Helsby et al., 2004) and LH7, LH17, LH32-34 and 400 
LH37 (Hu et al., 2003, Li et al., 2003, Hu et al., 2011). Nifurtimox and benznidazole were 401 
obtained from Simon Croft (London School of Hygiene and Tropical Medicine) and DFMO 402 
from Mike Barrett (University of Glasgow). 403 
 404 
Plasmids. The vectors used to delete Tbsnm1 from the T. brucei genome were generated as 405 
follows. Primers were designed to amplify 897 or 909 bp fragments from the 5’ Tbsnm1 406 
untranslated region and 3’ region of the Tbsnm1 gene, respectively. These were cloned 407 
sequentially either side of a puromycin- (pac) or blasticidin- (bla) containing resistance 408 
cassette. The constructs were linearized (SacI/KpnI for the pac vector or SacII/KpnI for the 409 
bla vector) then introduced into BSF T. brucei using the Human T-cell Nucleofector® kit and 410 
an Amaxa® Nucleofector™ (Lonza AG) set to program X-001. Integration of the DNA 411 
constructs into the T. brucei genome results in deletion of 60% of the Tbsnm1 open reading 412 
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frame (amino acids 1 to 425) including all of the non-canonical MBL domain. As this region 413 
is essential for Pso2p/SNM1 function (Li and Moses, 2003) removal of the MBL encoding 414 
DNA sequence from the trypanosomal genome would generate parasites lacking TbSNM1 415 
activity, effectively producing Tbsnm1 null mutant cells. 416 
The Tbsnm1 trypanosomal expression vector was generated as follows: a 2166 bp DNA 417 
sequence corresponding to full length Tbsnm1 was amplified from T. brucei genomic DNA 418 
using the primers cctgcaggATGGCAGGTGGA GCTGCAGGT and 419 
gcgcgccTTATTCTGAGTC ACTACTCAG (lower-case italics correspond to restriction sites 420 
incorporated into the primers to facilitate cloning), digested with SdaI/SgsI and ligated into 421 
the corresponding sites of vector pTubEX-LmSpSyn (Taylor et al 2008), replacing Lmspsyn.  422 
The NotI/XhoI digested construct was introduced into T. brucei wild type and Tbsnm1
-/-
 cells 423 
using nucleofection and recombinant clones selected. 424 
For the localisation construct a 2166 bp DNA sequence corresponding to full length 425 
Tbsnm1 was amplified from T. brucei genomic DNA using the primers 426 
tctagaGCAGGTGGAGCTGC AGGTAAG and gagatctTTATTCTGAGTCACT ACTCAG 427 
(lower-case italics correspond to restriction sites incorporated into the primers to facilitate 428 
cloning), the fragment digested with XbaI/BglII and ligated into the XbaI/BamHI sites of 429 
vector pRPaGFP-AT2 (Aslford et al., 2005) to replace the Tbat2 coding sequence.  The cloning 430 
was carried out such that the gene coding for the green fluorescence protein (GFP) was 431 
inserted in-frame at the 5’ end of the Tbsnm1-derived DNA fragment. The AscI digested 432 
construct was introduced into T. brucei 2T1 parasites. 433 
To construct the yeast complementation vector Tbsnm1 was amplified from the 434 
trypanosomal localisation plasmid using the primers tctagaGCAGGTGGAGCTGCAGGTAA 435 
G and aagcttTTATTCTGAGTCACTACTCAG (lower-case italics correspond to restriction 436 
sites incorporated into the primers to facilitate cloning). The resultant fragment was digested 437 
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with XbaI/HindIII and ligated into the corresponding sites of a pYCYlac111 derivative 438 
containing a DNA sequence encoding for the FLAG-tag epitope (Novoselova et al. 2013). 439 
The plasmid was transformed into yeast strains BY4742 and pso2∆. In this system 440 
recombinant TbSNM1 is tagged at its amino-terminus with a FLAG-tag epitope detectable 441 
with the anti-FLAG monoclonal antibody (Sigma). 442 
 443 
Localisation. BSF trypanosomes expressing GFP-TbSNM1 were washed twice in phosphate 444 
buffered saline (PBS), fixed in 2 % (w/v) paraformaldehyde/PBS and washed again in PBS. 445 
Aliquots of the cell suspension (105 cells) were then air dried onto microscope slides. Parasite 446 
DNA was stained using Vectashield Mounting Medium containing 4',6-diamidino-2-447 
phenylindole (DAPI) (Vectorshield Laboratories) and slides were viewed using a Leica SP5 448 
confocal microscope. 449 
 450 
Antiproliferative assays. All assays were performed in a 96-well plate format. T. brucei BSF 451 
parasites were seeded at 1 x 104 ml-1 in 200 µL growth medium containing different 452 
concentrations of compound. For UV irradiation, parasites were exposed to doses up to 900 J 453 
m-2 using a Stratalinker® UV crosslinker (Stratagene). After incubation at 37 oC for 3 days, 454 
2.5 µg resazurin (20 µL of 0.125 µg ml
-1
 stock in phosphate buffered saline) was added to 455 
each well and the plates incubated for a further 6-8 hours (Jones et al., 2010). Cell densities 456 
were determined by monitoring the fluorescence of each culture using a Gemini Fluorescent 457 
Plate Reader (Molecular Devices (UK) Ltd, Wokingham, UK) at an excitation wavelength of 458 
530 nm, emission wavelength of 585 nm and a filter cut off at 550 nm. The drug/treatment 459 
concentration that inhibits cell growth by 50% (IC50) was established using the non-linear 460 
regression tool on GraphPad Prism (GraphPad Software Inc.). 461 
  462 
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Yeast complementation assay. All assays were performed in a 96-well plate format. The cell 463 
density of overnight yeast cultures were equalised according to absorbance at 405 nm in 464 
medium containing different concentrations of mechlorethamine. The growth of each strain 465 
was then followed by monitoring the change in absorbance at 405 nm using an Absorbance 466 
Microplate Reader (BioTek Instruments Ltd). The % growth for each mechlorethamine-467 
treated culture after 18 hours relative to untreated samples was determined. 468 
 469 
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TABLE 698 
Table 1. Susceptibility of T. brucei lines to DNA damaging agents. The cell lines analysed 699 
were T. brucei (wild type) and T. brucei Tbsnm1-/- null mutants (Tbsnm1-/-). IC50 values are 700 
given in µM except for UV irradiation which is in J m
-1
. LH7, LH17, LH32-34, LH37, 701 
CB1954 and NH1 represent structures previously identified as trypanocidal agents (Bot et al., 702 
2010, Hall et al., 2010, Hu et al., 2011). nd is not determined. 703 
   704 
compound   T. brucei IC50 
wild type Tbsnm1
-/-
 
nitrogen mustards   
chlorambucil, cyclophosphamide, uramustine, 
trofosfamide, ifosfamide, bendamustine 
>30.000 nd 
mechlorethamine  34.240 ± 1.270 8.210 ± 1.180 
melphalan 8.660 ± 0.660 3.960 ± 0.320 
estramustine 9.370 ± 1.150 nd 
prednimustine  13.870 ± 1.330 nd 
   LH7 10.870 ± 0.240 0.580 ± 0.050 
   LH17 4.160 ± 0.130 0.380 ± 0.040 
   LH32 0.245 ± 0.079 0.021 ± 0.004 
   LH33 0.215 ± 0.008 0.015 ± 0.000 
   LH34 0.067 ± 0.006 0.006 ± 0.001 
   LH37 0.097 ± 0.009 0.005 ± 0.000 
aziridines   
thioTEPA  37.830 ± 1.730 13.880 ± 0.970 
triethylenemelamine 1.130 ± 0.150 0.300 ± 0.020 
mitomycin C 0.013 ± 0.001 0.010 ± 0.001 
   CB1954 3.900 ± 0.420 0.690 ± 0.050 
   NH1  0.120 ± 0.004 0.044 ± 0.013 
nitrosoureas   
carmustine, nimustine, NSC270516 >30.000 nd 
lomustine   16.650 ± 0.440 17.310 ± 0.210 
streptozotocin 21.800 ± 5.020 nd 
semustine 4.760 ± 0.050 3.780 ± 0.070 
alkyl sulfonate   
busulfan  >30.000 nd 
non-classical DNA crosslinking agents  
altretamine, pipobroman, dacarbazine, 
temozolomide, mitobronitol 
>30.000 nd 
platinum-based   
oxaliplatin, nedaplatin >30.000 nd 
cisplatin 2.280 ± 0.130 3.400 ± 0.280 
carboplatin 5.030 ± 0.040 nd 
Other agents   
   hydroxyurea 105.970 ± 10.190 88.200 ± 7.300 
   H2O2 43.710 ± 5.950 50.06 ± 7.520 
   UV irradiation  214.000 ± 13.000 196.000 ± 30.000 
   MMS 16.125 ± 1.379 14.020 ± 1.343 
   DMFO 24.150 ± 3.940 24.240 ± 6.710 
   nifurtimox 2.850 ± 0.020 2.250 ± 0.090 
   benznidazole 46.140 ± 1.440 37.680 ± 1.630 
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FIGURE LEGENDS 705 
Fig. 1. Sequence analysis of TbSNM1. The sequence corresponding to the metallo-ß-706 
lactamase (MBL; grey box) and β-CASP (hatched box) domains of TbSNM1 was aligned 707 
with other members of the SNM1A/PSO2 family of nucleases. The residues that are common 708 
with the TbSNM1 sequence are represented by dots. Sequence differences when compared 709 
with TbSNM1 are shown. In the alignments, amino acids marked with an asterisks (solid line 710 
in TbSNM1 schematic) correspond to motif 1-4, regions postulated to coordinate the metal 711 
(zinc) co-factor binding. The two possible residues that may represent motif 5 (5’ or 5’’; 712 
dotted line in TbSNM1 schematic) are also shown. The down arrow highlights the amino acid 713 
that distinguishes DNA from RNA processing metallo-β-lactamases while the RRRH 714 
sequence corresponds to a putative nuclear ‘pattern 4’ targeting signal. The sequences aligned 715 
are: T. brucei TbSNM1 (GenBank AAZ10739), Saccharomyces cerevisiae ScPSO2 716 
(NP_013857), Arabidopsis thaliana AtSNM1 (NP_189302) and Homo sapiens HsSNM1A 717 
(NP_001258745). 718 
 719 
Fig. 2. Complementation of the yeast pso2∆ mutation. A. Western blot analysis was 720 
carried out using a monoclonal antibody to the FLAG-tag epitope on cell extracts made from 721 
S. cerevisiae BY4742 (wild type) and pso2∆ strains expressing the FLAG epitope (control) or 722 
FLAG-TbSNM1. A band of ~80 kDa (indicated by **) was observed in lysates derived from 723 
cell expressing the recombinant trypanosomal protein. A cross reactive epitope (*) and 724 
Ponceau S staining of the membrane (not shown) were used as loading controls. B & C. The 725 
susceptibility of wild type and pso2∆ yeast strains expressing FLAG or FLAG-TbSNM1 to 726 
different concentrations of mechlorethamine. All data are mean values ± standard deviations 727 
from experiments performed in triplicate. In C, the values given in parenthesis represent the 728 
fold difference in IC50 values (in µM) relative to wild type controls. 729 
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Fig. 3. Localisation of TbSNM1 in bloodstream form T.brucei. A. Expression of GFP-730 
TbSNM1 was examined by probing a blot containing cell lysates from T. brucei wild type 731 
(lane 1) and GFP-TbSNM1 expressing cells (lane 2) using an anti-GFP antibody (upper 732 
panel). Protein from 1.5 x 107 cells was loaded in each track and a cross reactive epitope 733 
(lower panel) and by Coomassie staining (not shown) were used as loading controls. B. 734 
Parasites expressing GFP-TbSNM1 were co-stained with DAPI (DNA) and the cells 735 
examined by confocal microscopy. The TbSNM1 signal is coincidental with the nucleus (n; 736 
large DAPI spot); the smaller DAPI spot corresponds to the kinetoplast (k), the trypanosome 737 
mitochondrial genome. 738 
 739 
Fig. 4. Disruption of Tbsnm1 in T. brucei. A. Diagram of the Tbsnm1 alleles and the effects 740 
of gene disruption. A 5’ Tbsnm1 flanking sequence and a 3’ Tbsnm1 coding region were 741 
amplified and cloned sequentially either side of a puromycin (pac) or blasticidin (bla) 742 
cassette (plus T. brucei tubulin intergenic elements required for processing of mRNA (hashed 743 
boxes). The dotted lines correspond to the probe used to check integration. The position of 744 
the predicted MluI sites plus the band sizes (in kbp) obtained after hybridisation are shown. 745 
B. Southern blot analysis of MluI digested genomic DNA from T. brucei (lane 1), Tbsnm1+/- 746 
bla and Tbsnm1+/- pac heterozygous clones (lanes 2 and 3 respectively) and a Tbsnm1-/- null 747 
mutant line (lane 4). Blots were hybridized with labelled 3’ region of sequences. Sizes given 748 
are in kbp.  749 
 750 
Fig. 5. Susceptibility of T. brucei lines expressing altered levels of TbSNM1 to DNA 751 
damaging agents. A. Growth inhibitory effects (expressed as IC50 values in µM or nM) of 752 
the T. brucei wild type, Tbsnm1-/- null mutant, Tbsnm1-/- expressing an ectopic copy of 753 
Tbsnm1 (Tbsnm1-/-+ Tbsmn1++) and T. brucei expressing elevated levels of Tbsnm1 (wild 754 
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type + Tbsmn1
++
) lines towards DNA damaging agents. Integration of the Tbsnm1 755 
expression vector into a single tubulin array was confirmed by Southern hybridization and 756 
expression evaluated through qPCR (data not shown). B. Growth inhibitory effects 757 
(expressed as IC50 values in µM or nM) of T. brucei wild type, Tbsnm1
-/- null mutant, T. 758 
brucei expressing an ectopic copy of Tbntr (wild type + Tbntr9e10++ and Tbsnm1-/- 759 
expressing elevated levels of Tbntr (Tbsnm1
-/-
 + Tbntr9e10
++
) towards DNA damaging 760 
agents. Expression of Tbntr was evaluated through qPCR (data not shown). Data in panels A 761 
and B are mean values ± standard deviations from experiments performed in quadruplicate. 762 
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Trypanosomiasis is of medical and veterinary importance across sub-Saharan Africa. Trypanosoma 
brucei, the causative agent of these infections, expresses a DNA repair enzyme that exhibits 
characteristics typical of PSO2/SNM1 family of nucleases. This activity although non-essential for the 
growth of bloodstream form parasites does play a key role in fixing the damage caused by DNA 
interstrand crosslinking agents. 
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